TRANSFORMATIVEMED INC.
Seattle, US · Delaware corporation · 1 known investors
Founders & leadership
DC
Douglas CusickExecutive Officer, Director
EV
Erik Van EatonExecutive Officer, Director
PW
Peter WeissExecutive Officer
DS
David StoneExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.2MraisedMay 2022 · 33 investors · Other TechnologyRule 506(b)
▶$1.2MraisedMay 2022 · 33 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nathan BaysDirector
- Joel MezistranoDirector
- David StoneExecutive Officer, Director
- Shawn DeWaneExecutive Officer, Director
- Erik Van EatonExecutive Officer
- Daniel RosenDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MofferedJul 2018 · Other TechnologyRule 506(b)
▶$5MofferedJul 2018 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas CusickExecutive Officer, Director
- Erik Van EatonExecutive Officer, Director
- Peter WeissExecutive Officer
- David StoneExecutive Officer, Director
- Offering amount
- $5M
- Minimum investment
- $50K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.